359 related articles for article (PubMed ID: 26918035)
1. Vitamin D and Colorectal, Breast, and Prostate Cancers: A Review of the Epidemiological Evidence.
Jacobs ET; Kohler LN; Kunihiro AG; Jurutka PW
J Cancer; 2016; 7(3):232-40. PubMed ID: 26918035
[TBL] [Abstract][Full Text] [Related]
2. The epidemiology of vitamin D and cancer incidence and mortality: a review (United States).
Giovannucci E
Cancer Causes Control; 2005 Mar; 16(2):83-95. PubMed ID: 15868450
[TBL] [Abstract][Full Text] [Related]
3. Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer.
Grant WB
Anticancer Res; 2020 Jan; 40(1):491-499. PubMed ID: 31892604
[TBL] [Abstract][Full Text] [Related]
4. The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.
Moukayed M; Grant WB
Rev Endocr Metab Disord; 2017 Jun; 18(2):167-182. PubMed ID: 28213657
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and Physical Activity in Patients With Colorectal Cancer: Epidemiological Evidence and Therapeutic Implications.
Morales-Oyarvide V; Meyerhardt JA; Ng K
Cancer J; 2016; 22(3):223-31. PubMed ID: 27341603
[TBL] [Abstract][Full Text] [Related]
6. Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812).
Crew KD; Anderson GL; Hershman DL; Terry MB; Tehranifar P; Lew DL; Yee M; Brown EA; Kairouz SS; Kuwajerwala N; Bevers T; Doster JE; Zarwan C; Kruper L; Minasian LM; Ford L; Arun B; Neuhouser M; Goodman GE; Brown PH
Cancer Prev Res (Phila); 2019 Jul; 12(7):481-490. PubMed ID: 31138522
[TBL] [Abstract][Full Text] [Related]
7. Circulating 25-Hydroxyvitamin D Concentration and Risk of Breast, Prostate, and Colorectal Cancers: The Melbourne Collaborative Cohort Study.
Heath AK; Hodge AM; Ebeling PR; Eyles DW; Kvaskoff D; Buchanan DD; Giles GG; Williamson EJ; English DR
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):900-908. PubMed ID: 30842127
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and cancer incidence in the Harvard cohorts.
Giovannucci E
Ann Epidemiol; 2009 Feb; 19(2):84-8. PubMed ID: 18291673
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
10. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D for cancer prevention: global perspective.
Garland CF; Gorham ED; Mohr SB; Garland FC
Ann Epidemiol; 2009 Jul; 19(7):468-83. PubMed ID: 19523595
[TBL] [Abstract][Full Text] [Related]
12. Molecular basis of the potential of vitamin D to prevent cancer.
Ingraham BA; Bragdon B; Nohe A
Curr Med Res Opin; 2008 Jan; 24(1):139-49. PubMed ID: 18034918
[TBL] [Abstract][Full Text] [Related]
13. Relationship of very low serum 25-hydroxyvitamin D
Maalmi H; Walter V; Jansen L; Chang-Claude J; Owen RW; Ulrich A; Schöttker B; Hoffmeister M; Brenner H
Eur J Epidemiol; 2017 Nov; 32(11):961-971. PubMed ID: 28884317
[TBL] [Abstract][Full Text] [Related]
14. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
[TBL] [Abstract][Full Text] [Related]
15. Circulating 25-Hydroxy Vitamin D Relative to Vitamin D Receptor Polymorphism after Vitamin D3 Supplementation in Breast Cancer Women: A Randomized, Double-Blind Controlled Clinical Trial.
Mohseni H; Hosseini SA; Amani R; Ekrami A; Ahmadzadeh A; Latifi SM
Asian Pac J Cancer Prev; 2017 Jul; 18(7):1953-1959. PubMed ID: 28749628
[TBL] [Abstract][Full Text] [Related]
16. Calcium plus vitamin D supplementation and the risk of colorectal cancer.
Wactawski-Wende J; Kotchen JM; Anderson GL; Assaf AR; Brunner RL; O'Sullivan MJ; Margolis KL; Ockene JK; Phillips L; Pottern L; Prentice RL; Robbins J; Rohan TE; Sarto GE; Sharma S; Stefanick ML; Van Horn L; Wallace RB; Whitlock E; Bassford T; Beresford SA; Black HR; Bonds DE; Brzyski RG; Caan B; Chlebowski RT; Cochrane B; Garland C; Gass M; Hays J; Heiss G; Hendrix SL; Howard BV; Hsia J; Hubbell FA; Jackson RD; Johnson KC; Judd H; Kooperberg CL; Kuller LH; LaCroix AZ; Lane DS; Langer RD; Lasser NL; Lewis CE; Limacher MC; Manson JE;
N Engl J Med; 2006 Feb; 354(7):684-96. PubMed ID: 16481636
[TBL] [Abstract][Full Text] [Related]
17. Response of Vitamin D Concentration to Vitamin D3 Administration in Older Adults without Sun Exposure: A Randomized Double-Blind Trial.
Schwartz JB; Kane L; Bikle D
J Am Geriatr Soc; 2016 Jan; 64(1):65-72. PubMed ID: 26782853
[TBL] [Abstract][Full Text] [Related]
18. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
19. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin D and omega-3 fatty acids co-supplementation on inflammatory biomarkers, tumor marker CEA, and nutritional status in patients with colorectal cancer: a study protocol for a double blind randomized controlled trial.
Haidari F; Abiri B; Iravani M; Razavi SM; Sarbakhsh P; Ahmadi-Angali K; Vafa M
Trials; 2019 Dec; 20(1):682. PubMed ID: 31815661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
